Exclusive Online Content
Dublin-Based Innopharma Technology Announces Strategic Collaboration With Glatt
Dublin-based Innopharma Technology and Glatt (India) Systems Pvt. Ltd. have recently announced a strategic collaboration that is set to reduce product manufacturing costs…
Disease-Modifying Drugs Will Propel Huntington’s Disease Market to $2.6 Billion
The Huntington’s disease market will rise from around $252.6 million in 2014 to over $2.6 billion in 2024, representing a huge Compound Annual Growth Rate…
Meggle Announces New Head of Sales & Marketing
The Business Group Excipients & Technology of MEGGLE announced the appointment of Dr. Albrecht Kraemer, as its new Head of Sales & Marketing as…
Heart Failure Market to Soar to $11.8 Billion by 2025
The heart failure market is set to rise from around $3.2 billion in 2015 to $11.8 billion by 2025, representing a compound annual growth rate…
INTERPHEX & Industry Experts Select Nemera as Winner for Best New Product
International Pharmaceutical Expo (INTERPHEX), the premier event dedicated to pharmaceutical and biotechnology innovation, technology, and knowledge from development through commercialization and sponsored by the Parenteral…
First Gene Therapy Claims to be Successful Against Human Aging
Elizabeth Parrish, CEO of Bioviva USA Inc. has become the first human being to be successfully rejuvenated by gene therapy, after her own company’s experimental…
Bristol-Myers Squibb & Merck in Race to Dominate Head & Neck Cancer Market
Bristol-Myers Squibb & Merck in Race to Dominate Head & Neck Cancer Market Bristol-Myers Squibb (BMS) and Merck & Co. are set to continue…
Multi-Blockbuster Drugs Will Drive Immuno-Oncology Market to $34 Billion by 2024
The total immuno-oncology market will be worth approximately $14 billion by 2019, rising to $34 billion by 2024, as the treatment of cancer patients undergoes…
Patheon Selected By Grünenthal to Develop Drugs Using INTAC(R) Abuse-Deterrent Formulations Technology
Patheon, the leading global provider of pharmaceutical development and manufacturing services today announced it has signed a strategic agreement with Grünenthal, an independent, family-owned,…
AAI Pharma Services Corporation & Cambridge Major Laboratories Are Now Alcami
AAIPharma Services Corporation (AAI) / Cambridge Major Laboratories, Inc. (CML), a leading provider of custom development and manufacturing services for the pharmaceutical and biotechnology industries, recently announced its…
Aptar Pharma Launches eDose Counter for MDIs Integrating Proprietary Sensing Technology
Aptar Pharma, a global solution provider of innovative and proven aerosol, injection, and spray delivery systems for biotech, healthcare, and pharma products, will unveil…
World Excipients Market Expected to Reach $6.4 Billion by 2020
A new report published by Allied Market Research titled World Excipients Market-Opportunities and Forecasts, 2014-2020 projects that the world excipients market would reach $6.4 billion…
Global Viral Infections Market to Reach $117.6 Billion
The global viral infections market will grow from $74 billion in 2014 to $117.6 billion by 2021, representing a compound annual growth rate of 6.8%,…
WellSpring Pharma Services Completes $3-Million Capital Investment & Forms New Partnership
WellSpring Pharma Services, leading specialists in formulation, development and manufacturing for a wide range of solid, semi-solid and non-sterile liquid products, has announced a $3…
Huge Opportunities Remain for Premium-Priced Tyrosine Kinase Inhibitors in Pulmonary Arterial Hypertension
The Pulmonary Arterial Hypertension (PAH) space, which is currently burdened by significant unmet need, could benefit substantially from a class of drugs known as Tyrosine…
Paragon Bioservices Recognized as Best Contract Manufacturing Organization
Paragon Bioservices, Inc., a global leader in the manufacturing of biopharmaceuticals and vaccines, announced today that it was selected as the "Best Contract Manufacturing Organization"…
Crown Bioscience Strengthens Immuno-Oncology Capabilities With HuGEMM
Crown Bioscience, a wholly owned subsidiary of Crown Bioscience International (TWSE: ticker 6554), a global drug discovery and development services company providing translational platforms to…
Exclusive: Capsugel Prepares to Explore Sale or IPO
By: Carl O’Donnell & Greg Roumeliotis Capsugel, a U.S. maker of capsule products and other drug delivery systems, is preparing to explore a sale or…
Ascendia Pharma Announces New Contract Manufacturing Capability to Deliver cGMP Phase I Clinical Trial Materials
Ascendia now offers cGMP manufacturing capabilities for both oral and parenteral dosage forms to support your Phase I clinical trials. We have recently finished the qualification…
Gastric Cancer Drug Development Shifting From Small Molecules to Monoclonal Antibodies
While 99% of currently marketed gastric cancer drugs are small molecules, this dominance could give way to more innovative treatments in future, as the pipeline…
